Glipatab-M 50/500

 Product Benefits (Empagliflozin 5 mg + Metformin 500 mg)

• Dual Mechanism of Action: Combines the effects of Empagliflozin (increases glucose excretion via urine) and Metformin (decreases glucose production in the liver and increases insulin sensitivity) for comprehensive blood sugar lowering.

• Effective Blood Sugar Control: Significantly improves glycemic control in adults with Type 2 Diabetes, particularly when Metformin alone is insufficient.

• Potential Cardiovascular Benefits: Empagliflozin, the SGLT2 component, has demonstrated cardiovascular risk reduction in certain patients with Type 2 Diabetes and established cardiovascular disease.

• Aids Weight Management: The mechanism of Empagliflozin leads to caloric loss through urinary glucose excretion, which can support weight loss.

• Possible Blood Pressure Reduction: SGLT2 inhibitors may contribute to a modest reduction in blood pressure.

• Convenient Combination: Offers the benefit of two drugs in a single tablet, simplifying the medication regimen.

Disclaimer: This information is for SEO and general knowledge purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a healthcare professional for specific medical guidance regarding dosage and suitability.